These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36477737)

  • 1. Proteomic mapping of intercellular synaptic environments
    Bechtel TJ; Bertoch JM; Olow AK; Duich M; White CH; Reyes-Robles T; Fadeyi OO; Oslund RC
    Org Biomol Chem; 2022 Dec; 21(1):98-106. PubMed ID: 36477737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-1 on immature and PD-1 ligands on migratory human Langerhans cells regulate antigen-presenting cell activity.
    Peña-Cruz V; McDonough SM; Diaz-Griffero F; Crum CP; Carrasco RD; Freeman GJ
    J Invest Dermatol; 2010 Sep; 130(9):2222-30. PubMed ID: 20445553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of cell-cell interactions via photocatalytic cell tagging.
    Oslund RC; Reyes-Robles T; White CH; Tomlinson JH; Crotty KA; Bowman EP; Chang D; Peterson VM; Li L; Frutos S; Vila-Perelló M; Vlerick D; Cromie K; Perlman DH; Ingale S; Hara SDO; Roberts LR; Piizzi G; Hett EC; Hazuda DJ; Fadeyi OO
    Nat Chem Biol; 2022 Aug; 18(8):850-858. PubMed ID: 35654846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A computational study of co-inhibitory immune complex assembly at the interface between T cells and antigen presenting cells.
    Su Z; Dhusia K; Wu Y
    PLoS Comput Biol; 2021 Mar; 17(3):e1008825. PubMed ID: 33684103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Assays to Study PD-1 Biology in Human T Cells.
    Tocheva AS; Lerrer S; Mor A
    Curr Protoc Immunol; 2020 Sep; 130(1):e103. PubMed ID: 32757378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and molecular regulation of the programmed death-1/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases.
    Ibañez-Vega J; Vilchez C; Jimenez K; Guevara C; Burgos PI; Naves R
    J Autoimmun; 2021 Sep; 123():102702. PubMed ID: 34311143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1 blocks lytic granule polarization with concomitant impairment of integrin outside-in signaling in the natural killer cell immunological synapse.
    Huang Y; Chen Z; Jang JH; Baig MS; Bertolet G; Schroeder C; Huang S; Hu Q; Zhao Y; Lewis DE; Qin L; Zhu MX; Liu D
    J Allergy Clin Immunol; 2018 Oct; 142(4):1311-1321.e8. PubMed ID: 29679656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and interactions of the human programmed cell death 1 receptor.
    Cheng X; Veverka V; Radhakrishnan A; Waters LC; Muskett FW; Morgan SH; Huo J; Yu C; Evans EJ; Leslie AJ; Griffiths M; Stubberfield C; Griffin R; Henry AJ; Jansson A; Ladbury JE; Ikemizu S; Carr MD; Davis SJ
    J Biol Chem; 2013 Apr; 288(17):11771-85. PubMed ID: 23417675
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Li K; Cheng X; Tilevik A; Davis SJ; Zhu C
    J Biol Chem; 2017 Apr; 292(16):6799-6809. PubMed ID: 28270509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Programmed cell death protein 1 and its ligands regulate immune balance in allergic rhinitis].
    Wen SL; Li F; Zhao F; Zuo JJ; Deng YQ; Zhang W; Tao ZZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Apr; 55(4):384-390. PubMed ID: 32306637
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells.
    Dilek N; Poirier N; Hulin P; Coulon F; Mary C; Ville S; Vie H; Clémenceau B; Blancho G; Vanhove B
    PLoS One; 2013; 8(12):e83139. PubMed ID: 24376655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of programmed death 1 ligands by murine T cells and APC.
    Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H
    J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
    Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
    J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmed death-ligand 1 expression in swine chronic infections and enhancement of interleukin-2 production via programmed death-1/programmed death-ligand 1 blockade.
    Ganbaatar O; Konnai S; Okagawa T; Nojima Y; Maekawa N; Ichikawa Y; Kobayashi A; Shibahara T; Yanagawa Y; Higuchi H; Kato Y; Suzuki Y; Murata S; Ohashi K
    Immun Inflamm Dis; 2021 Dec; 9(4):1573-1583. PubMed ID: 34414683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence-specific
    Walker K; Waters LC; Kelly G; Muskett FW; Carr MD
    Biomol NMR Assign; 2022 Oct; 16(2):281-288. PubMed ID: 35675028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking PD-1/PD-L1 by an ADCC enhanced anti-B7-H3/PD-1 fusion protein engages immune activation and cytotoxicity.
    Xu Y; Xiao Y; Luo C; Liu Q; Wei A; Yang Y; Zhao L; Wang Y
    Int Immunopharmacol; 2020 Jul; 84():106584. PubMed ID: 32422527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-1 as an immune modulatory receptor.
    Yao S; Chen L
    Cancer J; 2014; 20(4):262-4. PubMed ID: 25098286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential binding properties of B7-H1 and B7-DC to programmed death-1.
    Youngnak P; Kozono Y; Kozono H; Iwai H; Otsuki N; Jin H; Omura K; Yagita H; Pardoll DM; Chen L; Azuma M
    Biochem Biophys Res Commun; 2003 Aug; 307(3):672-7. PubMed ID: 12893276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
    Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.
    Paterson AM; Brown KE; Keir ME; Vanguri VK; Riella LV; Chandraker A; Sayegh MH; Blazar BR; Freeman GJ; Sharpe AH
    J Immunol; 2011 Aug; 187(3):1097-105. PubMed ID: 21697456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.